Abstract
Small cell prostate carcinoma is a lethal variant of castration-resistant prostate cancer. Beltran and colleagues identified overexpression and amplification of both aurora kinase A (AURKA) and the MYCN protooncogene in the small cell prostate carcinomas and propose Aurora kinase A as a potential therapeutic target in this disease subset.
Original language | English (US) |
---|---|
Pages (from-to) | 466-468 |
Number of pages | 3 |
Journal | Cancer discovery |
Volume | 1 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2011 |
ASJC Scopus subject areas
- Oncology